New therapeutic strategies for squamous cell cancer and adenocarcinoma.
Autor: | Wijnhoven BPL; Department of Surgery, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands., Toxopeus ELA; Department of Surgery, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands., Vallböhmer D; Department of General, Visceral and Pediatric Surgery, University of Düsseldorf, Düsseldorf, Germany., Knoefel WT; Department of General, Visceral and Pediatric Surgery, University of Düsseldorf, Düsseldorf, Germany., Krasna MJ; Jersey Shore University Medical Center, Neptune, New Jersey., Perez K; Division of Hematology - Oncology, Warren Alpert School of Medicine, Brown University, Providence, Rhode Island., van Rossum PSN; Departments of Surgery and Radiotherapy, University Medical Center, Utrecht, The Netherlands., Ruurda JP; Departments of Surgery and Radiotherapy, University Medical Center, Utrecht, The Netherlands., van Hillegersberg R; Departments of Surgery and Radiotherapy, University Medical Center, Utrecht, The Netherlands., Schiesser M; Department of Surgery, University Hospital Zurich, Zurich, Switzerland., Schneider P; Department of Surgery, University Hospital Zurich, Zurich, Switzerland., Felix VN; FMUSP and Nucleus of General and Specialized Surgery, Sao Paulo, Brazil. |
---|---|
Jazyk: | angličtina |
Zdroj: | Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2013 Oct; Vol. 1300, pp. 213-225. |
DOI: | 10.1111/nyas.12247 |
Abstrakt: | This paper presents commentaries on neoadjuvant treatment esophagectomy; the prognostic and predictive effects of single nucleotide polymorphisms (SNP) in the multimodality therapy of esophageal cancer; optimal preoperative treatment prior to surgery for esophageal cancer; a possible role for trastuzumab in treating esophageal adenocarcinoma or any esophageal dysplasia/intra-epithelial neoplasia; surgery after chemoradiation in resectable esophageal cancer; whether para-aortic lymph node dissection should be performed in esophagogastric junction (EGJ) tumors; and transhiatal esophagectomy in treatment of the esophageal cancer. (© 2013 New York Academy of Sciences.) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |